Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders

Neurologists warn that GLP-1 agonists like Ozempic and Wegovy, which promote rapid weight loss, may worsen neurodegenerative conditions such as ALS by accelerating physical decline. A case report shows an ALS patient’s condition deteriorated after using semaglutide, stabilizing only after discontinuation.